Preventing cognitive decline: what have we learned from J-MINT
On site
Online
Information
Event
Date
Tuesday, March 23, 2027
Time
08:00 – 08:45
Duration
45 min
Credits
1 CME credit (pending approval)
Language
English
Objectives
Interpret key outcomes and limitations of the J-MINT trial.
Assess multimodal interventions for reducing risk of cognitive decline.
Apply J-MINT findings to prevention strategies in at-risk older adults.
Access
Provider
Klinik Barmelweid
On site
Online
As a webinar on geriatrics-update.com. You’ll receive the access link by email in advance or directly on this page.
Speaker
Prof. Hidenori Arai,
President, National Center for Geriatrics and Gerontology
Hidenori Arai (MD, PhD) is a geriatrician and the President of the National Center for Geriatrics and Gerontology (NCGG), Japan. He is also the President of the Japanese Association on Sarcopenia and Frailty. After graduating from Kyoto University School of Medicine in 1984, he became a Professor in the Department of Human Health Science at Kyoto University School of Medicine in 2009. Then, he moved to NCGG as the Deputy Director in 2015. He became the Director in 2018 and the President of NCGG in 2019. He is a co-chairman of the Asian Working Group for Sarcopenia and the Asian Working Group for Cachexia and is Chairman of the IAGG-Asia Oceania Region. He is a PI of the J-MINT, which is a multidomain intervention for dementia prevention. His primary research interest is frailty, sarcopenia, and dementia prevention for healthy aging.
Dear colleagues,
dear friends and supporters of geriatric medicine,
It is my great pleasure to welcome you to the continuation of our Geriatrics Seminar Series. With the 2026 annual program, we once again set new standards – scientifically, didactically, and in terms of content – while continuing our mission to further develop geriatrics as an academically grounded, interdisciplinary, and forward-looking field. Geriatrics operates at the intersection of medicine, technology, and society – and it is precisely here that we aim to build bridges, connecting clinical excellence, research, and education. Geriatrics exemplifies the medicine of the future: complex, interconnected, and profoundly human.
With international participation, innovative formats, and a clear scientific focus, we are creating a space for reflection, exchange, and progress. A major milestone is the new interactive platform geriatrics-update.com – a digital knowledge network that links continuing education, research, and clinical practice. It enables direct dialogue between clinical care, science, and society, and is unique in its form in Switzerland.
The 2026 program reflects the breadth and depth of modern geriatric medicine: from longevity and muscle health to delirium management, digitalization and artificial intelligence, geriatric oncology, empathy, and ethical leadership. These topics mirror the evolution of a discipline that extends far beyond daily clinical work, touching on fundamental questions of quality of life, meaning, and sustainability.
Our aspiration remains unchanged: We combine scientific excellence with compassionate care – and actively shape the future of healthy aging. My heartfelt thanks go to all speakers and participants whose expertise and enthusiasm make the Barmelweid Geriatrics Seminar Series recognized far beyond Switzerland’s borders as a place of learning, encounter, and innovation.
Yours sincerely,
PD Dr. med. Mathias Schlögl,
Chefarzt Geriatrie, Klinik Barmelweid
Organised by
